Sex-dependent differences in rat hepatic lipid accumulation and insulin sensitivity in response to diet-induced obesity

Biochemistry and Cell Biology

Volumn 90, Issue 2, 2012, Pages 164-172

  Nadal Casellas, Antònia ^a,b   Proenza, Ana Maria ^a,b   Lladó, Isabel ^a,b   Gianotti, Magdalena ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

High fat diet; Insulin; Liver; Obesity; Sexual dimorphism

Indexed keywords

ADIPOSE TISSUE; BODY MASS; DIET-INDUCED OBESITY; DIETARY TREATMENTS; FAT ACCUMULATION; FEMALE RAT; GLUCOSE TOLERANCE; HIGH-FAT DIET; IN-CONTROL; INSULIN RECEPTORS; INSULIN SENSITIVITY; INSULIN SIGNALING; KINASE A; LIPID ACCUMULATIONS; LIPID CONTENT; MRNA EXPRESSION; OBESITY; PROTEIN LEVEL; PYRUVATE DEHYDROGENASE KINASE; SEXUAL DIMORPHISM; STORAGE CAPACITY; WISTAR RAT;

ENZYMES; INSULIN; LIVER; PIGMENTS; RATS; TISSUE;

NUTRITION;

ADIPOCYTOKINE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 2; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE KINASE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DIET; DIETARY OBESITY; FEMALE; FOOD COMPOSITION; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIPOTOXICITY; LIVER DISEASE; LIVER WEIGHT; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN CONTENT; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ADIPONECTIN; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; ENERGY INTAKE; FEMALE; GENETIC VARIATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; OBESITY; ORGAN SIZE; PPAR ALPHA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SEX FACTORS; TRIGLYCERIDES;

EID: 84862736562     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-069     Document Type: Article

References (45)

1. Aguirre V. Werner E.D. Giraud J. Lee Y.H. Shoelson S.E. White M.F. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277 (2): 1531-1537. 10.1074/jbc.M101521200 11606564
2. Biddinger S.B. Hernandez-Ono A. Rask-Madsen C. Haas J.T. Aleman J.O. Suzuki R. et al. 2008. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7 (2): 125-134. 10.1016/j.cmet.2007.11.013 18249172
3. Blüher M. Michael M.D. Peroni O.D. Ueki K. Carter N. Kahn B.B. Kahn C.R. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell, 3 (1): 25-38. 10.1016/S1534-5807(02)00199-5 12110165
4. Bradford M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1-2): 248-254. 10.1016/0003-2697(76)90527-3 942051
5. Carmona M.C. Louche K. Nibbelink M. Prunet B. Bross A. Desbazeille M. et al. 2005. Fenofibrate prevents rosiglitazone-induced body weight gain in ob/ob mice. Int. J. Obes. (Lond.), 29 (7): 864-871. 10.1038/sj.ijo.0802943 15917863
6. Chiarugi P. Fiaschi T. 2010. Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration. Expert Opin. Ther. Targets, 14 (2): 193-206. 10.1517/14728220903530712 20017651
7. Duckworth W.C. Bennett R.G. Hamel F.G. 1998. Insulin degradation: progress and potential. Endocr. Rev. 19 (5): 608-624. 10.1210/er.19.5.608 9793760
8. Eaton R.P. Friedman N. Allen R.C. Schade D.S. 1984. Insulin removal in man: in vivo evidence for a receptor-mediated process. J. Clin. Endocrinol. Metab. 58 (3): 555-559. 10.1210/jcem-58-3-555 6363442
9. Eriksson J.W. 2007. Metabolic stress in insulin's target cells leads to ROS accumulation ' a hypothetical common pathway causing insulin resistance. FEBS Lett. 581 (19): 3734-3742. 10.1016/j.febslet.2007.06.044 17628546
10. Exton J.H. Mallette L.E. Jefferson L.S. Wong E.H. Friedmann N. Miller T.B. Jr Park C.R. 1970. The hormonal control of hepatic gluconeogenesis. Recent Prog. Horm. Res. 26: 411-461. 4319350
11. Folch J. Lees M. Sloane Stanley G.H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1): 497-509. 13428781
12. Fridlyand L.E. Philipson L.H. 2006. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8 (2): 136-145. 10.1111/j.1463-1326.2005.00496.x 16448517
13. Gómez-Pérez Y. Amengual-Cladera E. Català-Niell A. Thomas-Moyà E. Gianotti M. Proenza A.M. Lladó I. 2008. Gender dimorphism in high-fat-diet-induced insulin resistance in skeletal muscle of aged rats. Cell. Physiol. Biochem. 22 (5-6): 539-548. 10.1159/000185538 19088436
14. Hirosumi J. Tuncman G. Chang L. Gorgun C.Z. Uysal K.T. Maeda K. et al. 2002. A central role for JNK in obesity and insulin resistance. Nature, 420 (6913): 333-336. 10.1038/nature01137 12447443
15. Jeoung N.H. Harris R.A. 2008. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am. J. Physiol. Endocrinol. Metab. 295 (1): E46-E54. 10.1152/ajpendo.00536.2007 18430968
16. Jeoung N.H. Harris R.A. 2010. Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J. 34 (5): 274-283. 10.4093/kdj.2010.34.5.274 21076574
17. Karlsson S. Scheurink A.J. Ahren B. 2002. Gender difference in the glucagon response to glucopenic stress in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (1): R281-R288. 11742849
18. Kautzky-Willer A. Handisurya A. 2009. Metabolic diseases and associated complications: sex and gender matter! Eur. J. Clin. Invest. 39 (8): 631-648. 10.1111/j.1365-2362.2009.02161.x 19496803
19. Kraegen E.W. Clark P.W. Jenkins A.B. Daley E.A. Chisholm D.J. Storlien L.H. 1991. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes, 40 (11): 1397-1403. 10.2337/diabetes.40.11.1397 1936601
20. Kumagai S. Holmang A. Bjorntorp P. 1993. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol. Scand. 149 (1): 91-97. 10.1111/j.1748-1716.1993.tb09596.x 8237427
21. Leavens K.F. Easton R.M. Shulman G.I. Previs S.F. Birnbaum M.J. 2009. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10 (5): 405-418. 10.1016/j.cmet.2009.10.004 19883618
22. Maasen J.A. 2008. Mitochondria, body fat and type 2 diabetes: what is the connection? Minerva Med. 99 (3): 241-251. 18497722
23. Marra F. Gastaldelli A. Svegliati Baroni G. Tell G. Tiribelli C. 2008. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14 (2): 72-81. 10.1016/j.molmed.2007.12.003 18218340
24. Michael M.D. Kulkarni R.N. Postic C. Previs S.F. Shulman G.I. Magnuson M.A. Kahn C.R. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell, 6 (1): 87-97. 10949030
25. Miyazaki Y. Glass L. Triplitt C. Matsuda M. Cusi K. Mahankali A. et al. 2001. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients. Diabetologia, 44 (12): 2210-2219. 10.1007/s001250100031 11793023
26. Nadal-Casellas A. Amengual-Cladera E. Proenza A.M. Llado I. Gianotti M. 2010. Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats. Cell. Physiol. Biochem. 26 (3): 291-302. 10.1159/000320552 20798513
27. Ono H. Shimano H. Katagiri H. Yahagi N. Sakoda H. Onishi Y. et al. 2003. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes, 52 (12): 2905-2913. 10.2337/diabetes.52.12.2905 14633850
28. Petersen K.F. Dufour S. Befroy D. Lehrke M. Hendler R.E. Shulman G.I. 2005. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes, 54 (3): 603-608. 10.2337/diabetes.54.3.603 15734833
29. Pickavance L.C. Wilding J.P. 2007. Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker diabetic fatty rat. Diabetes Obes. Metab. 9 (1): 114-120. 10.1111/j.1463-1326.2006.00586. x 17199726
30. Reshef L. Olswang Y. Cassuto H. Blum B. Croniger C.M. Kalhan S.C. et al. 2003. Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278 (33): 30413-30416. 10.1074/jbc.R300017200 12788931
31. Saltiel A.R. Kahn C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414 (6865): 799-806. 10.1038/414799a 11742412
32. Sanyal A.J. Campbell-Sargent C. Mirshahi F. Rizzo W.B. Contos M.J. Sterling R.K. et al. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120 (5): 1183-1192. 10.1053/gast.2001.23256 11266382
33. Serrano R. Villar M. Gallardo N. Carrascosa J.M. Martinez C. Andres A. 2009. The effect of aging on insulin signalling pathway is tissue dependent: central role of adipose tissue in the insulin resistance of aging. Mech. Ageing Dev. 130 (3): 189-197. 10.1016/j.mad.2008.11.005 19063913
34. Sims E.A. 2001. Are there persons who are obese, but metabolically healthy? Metabolism, 50 (12): 1499-1504. 10.1053/meta.2001.27213 11735101
35. Sugden M.C. Holness M.J. 2003. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am. J. Physiol. Endocrinol. Metab. 284 (5): E855-E862. 12676647
36. Thomàs-Moyà E. Gianotti M. Proenza A.M. Lladó I. 2007. Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol. Med. 13 (3-4): 203-209. 10.2119/2006-00078.Thomas-Moya 17592556
37. Tiikkainen M. Hakkinen A.M. Korsheninnikova E. Nyman T. Makimattila S. Yki-Jarvinen H. 2004. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes, 53 (8): 2169-2176. 10.2337/diabetes.53.8.2169 15277403
38. Ueki K. Yamamoto-Honda R. Kaburagi Y. Yamauchi T. Tobe K. Burgering B.M. et al. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273 (9): 5315-5322. 10.1074/jbc.273.9.5315 9478990
39. van Herpen N.A. Schrauwen-Hinderling V.B. 2008. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol. Behav. 94 (2): 231-241. 10.1016/j.physbeh.2007.11.049 18222498
40. Virkamäki A. Ueki K. Kahn C.R. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103 (7): 931 - 943. 10.1172/JCI6609 10194465
41. Virtue S. Vidal-Puig A. 2010. Adipose tissue expandability, lipotoxicity and the metabolic syndrome'an allostatic perspective. Biochim. Biophys. Acta, 1801 (3): 338-349. 10.1016/j.bbalip.2009.12.006 20056169
42. Wu Z. Puigserver P. Andersson U. Zhang C. Adelmant G. Mootha V. et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98 (1): 115-124. 10.1016/S0092-8674(00) 80611-X 10412986
43. Xu A. Chan K.W. Hoo R.L. Wang Y. Tan K.C. Zhang J. et al. 2005. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280 (18): 18073-18080. 10.1074/jbc.M414231200 15760892
44. Yoon M. 2009. The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions. Pharmacol. Res. 60 (3): 151-159. 10.1016/j.phrs.2009.02.004 19646654
45. Zammit V.A. 2000. Use of in vivo and in vitro techniques for the study of the effects of insulin on hepatic triacylglycerol secretion in different insulinaemic states. Biochem. Soc. Trans. 28 (2): 103-109. 10816109